Pivotal Study to Validate a Novel System to Non-Invasively Detect Severe Neutropenia
Not yet recruiting
- Conditions
- Diffuse Large B Cell LymphomaMultiple Myeloma
- First Posted Date
- 2024-03-21
- Last Posted Date
- 2024-10-09
- Lead Sponsor
- Leuko Labs, Inc.
- Target Recruit Count
- 210
- Registration Number
- NCT06323447
Usability, Adherence and Diagnostic Performance of PointCheck in Pediatric Population
Completed
- Conditions
- Hematologic Malignancy
- Interventions
- Device: PointCheck
- First Posted Date
- 2021-05-17
- Last Posted Date
- 2025-03-11
- Lead Sponsor
- Leuko Labs, Inc.
- Target Recruit Count
- 46
- Registration Number
- NCT04889937
- Locations
- 🇺🇸
MD Anderson Cancer Center, Houston, Texas, United States
Study to Evaluate the Usability of PointCheck
Completed
- Conditions
- NeoplasmsChemotherapy-induced Neutropenia
- First Posted Date
- 2020-06-25
- Last Posted Date
- 2023-08-22
- Lead Sponsor
- Leuko Labs, Inc.
- Target Recruit Count
- 94
- Registration Number
- NCT04448314
- Locations
- 🇪🇸
Hospital Universitari Dexeus. Grupo Quirónsalud, Barcelona, Spain
🇪🇸Breast Unit. Oncology Department. 12 Octubre Hospital, Madrid, Spain
🇪🇸Hospital Universitario 12 de Octubre, Madrid, Spain
PC001- A Study to Evaluate the Usability of PointCheck
Not Applicable
Recruiting
- Conditions
- NeoplasmsNeutropenia
- Interventions
- Diagnostic Test: PointCheck
- First Posted Date
- 2020-06-25
- Last Posted Date
- 2025-03-11
- Lead Sponsor
- Leuko Labs, Inc.
- Target Recruit Count
- 100
- Registration Number
- NCT04448301
- Locations
- 🇺🇸
Boston Medical Center, Boston, Massachusetts, United States
© Copyright 2025. All Rights Reserved by MedPath